New FDA moves are boosting American jobs and protecting our medicine supply
policymakers have highlighted the vulnerabilities of relying on foreign supply chains for essential medicines. Yet over 70% of the primary manufacturing facilities for prescriptions filled in the United States remain outside our borders.
Reported by 1 outlet — Fox News Latest. See all sources ↓
policymakers have highlighted the vulnerabilities of relying on foreign supply chains for essential medicines. Yet over 70% of the primary manufacturing facilities for prescriptions filled in the United States remain outside our borders. Over time, a suffocating web of state and federal regulations meant that companies investing millions or billions to build facilities in the U.S. would see those investments sit idle for up to 14 months waiting for standard post-construction reviews.
Read the full report at Fox News Latest ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- policymakers have highlighted the vulnerabilities of relying on foreign supply chains for essential medicines. Yet over 70% of the primary manufacturing facilities for prescriptions filled in the United States remain outside our borders.
- How widely is it covered?
- 1 outlet, average source rating 6.0/10.
- When was it last updated?
- 12m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
New FDA moves are boosting American jobs and protecting our medicine supply
Sources1TypeCoverageFox News Latest